The NIH Institutional Biosafety Committee (IBC) provides recommendations to the Director of the NIH or his designee, in matters pertaining to the control of hazards associated with the intramural use of microbiological agents, their vectors, and recombinant DNA. The committee serves as an advisory body to the Division of Safety (DS), Office of Research Services (ORS).
Recombinant DNA and Pathogen Registration submissions are submitted electronically through the
Electronic Registration System (ERS). Please check the NIH:
IBC Meeting and Deadline Dates for Bethesda campus and RML IBC Meeting and Deadline Dates for Rocky Mountain Lab (RML) campus. Membership roster for RML IBC Committee: RML IBC Membership.
Read more from the Charter for the NIH Institutional Biosafety Committee.
View Public Posting of Institutional Biosafety Committee (IBC) Minutes
Membership Roster
| Name | Committee Role |
|---|
| Harry L. Malech | Chairperson, Clinican |
| Richard G. Baumann | Biological Safety Officer, Voting Contact |
| Robert Craigie | Committee Member, Clinician |
| Alicia Alexion | Local Non-Affiliated |
| Jocelyn Dunford-Weissman | Senior Research Associate
|
| Avijeet( and Ishveen) Chopra | Scientific Technical Writers
|
| Althea Treacy | Associate Biological Safety Officer, QPSO Lead |
| Lauren Reoma | Committee Member, Clinician |
| Jeanne Billioux | Committee Member, Clinician |
| Michael Kujawa | Commmittee Member, IBC Coordinator |
| Stephen L. Denny | Animal Expert, Animal Program Director |
| Clevetta Drew | Local Non-Affiliated |
| Stephanie M. Goff | Committee Member |
| Steve S. Whitehead | Committee Member, Virologist
|
